Cholesterol Crystals Induce Complement-Dependent Inflammasome Activation and Cytokine Release
Eivind Ottersen Samstad, Nathalie Niyonzima, Stig Haugset Nymo et al. · The Journal of Immunology · 2014
Inflammation is associated with development of atherosclerosis, and cholesterol crystals (CC) have long been recognized as a hallmark of atherosclerotic lesions. CC appear early in the atheroma development and trigger inflammation by NLRP3 inflammasome activation. In this study we hypothesized whether CC employ the complement system to activate inflammasome/caspase-1, leading to release of mature IL-1β, and whether complement activation regulates CC-induced cytokine production. In this study we describe that CC activated both the classical and alternative complement pathways, and C1q was found to be crucial for the activation. CC employed C5a in the release of a number of cytokines in whole blood, including IL-1β and TNF. CC induced minimal amounts of cytokines in C5-deficient whole blood, until reconstituted with C5. Furthermore, C5a and TNF in combination acted as a potent primer for CC-induced IL-1β release by increasing IL-1β transcripts. CC-induced complement activation resulted in upregulation of complement receptor 3 (CD11b/CD18), leading to phagocytosis of CC. Also, CC mounted a complement-dependent production of reactive oxygen species and active caspase-1. We conclude that CC employ the complement system to induce cytokines and activate the inflammasome/caspase-1 by regulating several cellular responses in human monocytes. In light of this, complement inhibition might be an interesting therapeutic approach for treatment of atherosclerosis.
Cited by 289 works. doi:10.4049/jimmunol.1302484
Authors
- Eivind Ottersen Samstad
- Nathalie Niyonzima
- Stig Haugset Nymo
- Liv Ryan
- Siril Skaret Bakke
- Knut Tore Lappegård
- Ole‐Lars Brekke
- John D. Lambris
- Jan Kristian Damås
- Eicke Latz
- Tom Eirik Mollnes
- Terje Espevik
References
- A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
- Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- The Inflammasomes: Guardians of the Body
- Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
- Complement: a key system for immune surveillance and homeostasis
- A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
- Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
- CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
- Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation